Please join us for our upcoming CAS BioFinder™ Discovery Platform webinar series! During this series, we will discuss common use cases for using CAS BioFinder™ to accelerate your Drug Discovery process.
Examination of Tyrosine-Protein Kinase JAK as a Target for Cancer
When trying to engage in drug discovery for therapeutics capable of treating a disease, many decisions must be made. Access to the data necessary to make as many of these decisions as possible in one place could make scientists working in this field much more efficient. CAS BioFinder™ is an example of such a solution. To research targeting cancer through the inhibition of Tyrosine-Protein Kinase JAK, we will demonstrate the ability to access such information as:
- All published activity data for ligands against specific targets and diseases
- Molecular scaffolds obtained from ligands that are most active against a given target or disease
- Prioritized known or novel compounds to pursue by generating predictive molecular characteristics and predicting potential off-target activities
- The crystal structures of protein targets to visualize and probe for binding pockets
- Research approaches to modulating disease through access to biopathways and relevant biomarkers
Gary Gustafson and Henry Valle
Registration Link:
https://casevents.webex.com/weblink/register/r1c382a70d16475e173265e0dcf1d6534
Please feel free to forward this invitation to any of your colleagues.
We look forward to seeing you!
LinkedIn for Andrew Dunn (Customer Success Manager for Academics) : www.linkedin.com/in/andrew-dunn-80a093a6
LinkedIn for CAS: https://www.linkedin.com/company/cas/
